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Abstract
Background: By using whole genome sequence data we aimed at describing a population snapshot of
carbapenemase-producing K. pneumoniae isolated from hospitalized patients in Germany between 2008 and 2014.
Methods: We selected a representative subset of 107 carbapenemase-producing K. pneumoniae clinical isolates
possessing the four most prevalent carbapenemase types in Germany (KPC-2, KPC-3, OXA-48, NDM-1). Isolates were
processed via illumina NGS. Data were analysed using different SNP-based mapping and de-novo assembly
approaches. Relevant information was extracted from NGS data (antibiotic resistance determinants, wzi gene/cps
type, virulence genes). NGS data from the present study were also compared with 238 genome data from two
previous international studies on K. pneumoniae.
Results: NGS-based analyses revealed a preferred prevalence of KPC-2-producing ST258 and KPC-3-producing ST512
isolates. OXA-48, being the most prevalent carbapenemase type in Germany, was associated with various K.
pneumoniae strain types; most of them possessing IncL/M plasmid replicons suggesting a preferred dissemination of
blaOXA-48 via this well-known plasmid type. Clusters ST15, ST147, ST258, and ST512 demonstrated an intermingled
subset structure consisting of German and other European K. pneumoniae isolates. ST23 being the most frequent MLST
type in Asia was found only once in Germany. This latter isolate contained an almost complete set of virulence genes
and a K1 capsule suggesting occurrence of a hypervirulent ST23 strain producing OXA-48 in Germany.
Conclusions: Our study results suggest prevalence of “classical” K. pneumonaie strain types associated with widely
distributed carbapenemase genes such as ST258/KPC-2 or ST512/KPC-3 also in Germany. The finding of a supposed
hypervirulent and OXA-48-producing ST23 K. pneumoniae isolates outside Asia is highly worrisome and requires intense
molecular surveillance.
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Background
Third-generation cephalosporin-resistant and carbapenem-
resistant Klebsiella pneumoniae are important health-care
pathogens associated with increased morbidity and mor-
tality among high-risk patients. Recent data from the
European Antimicrobial Resistance Surveillance network
(EARS-Net) for health-care associated pathogens (from
invasive infections) constitute a rising number of third-
generation cephalosporin-resistant and carbapenem-
resistant K. pneumoniae all over Europe [1]. In the period
2012 to 2015 some countries, such as Spain, Portugal and
Croatia, experienced rising trends of carbapenem resist-
ance still at a low level (< 4%) but triggering the overall
European trend. In other countries such as Romania, Italy,
and Greece, the rates were already much higher and, in
addition, partly showed an increasing trend (Romania). In
contrast to this, the majority of European countries, in-
cluding Germany demonstrated rates below 1% without
showing any significant development in recent years.
Thus, Germany could be considered as a low-prevalence
country according to EARS-Net data regarding the
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occurrence and spread of carbapenem-resistant K.
pneumoniae. However, the National Reference Centre
(NRC) for Gram-negative nosocomial pathogens in
Germany is challenged by analysing an increasing number
of several thousand carbapenem-resistant Enterobacteria-
ceae, Pseudomonas aeruginosa and Acinetobacter each
year, starting with only a few hundred isolates back in
2008/2009. In 2015 and 2016 diagnostic laboratories
throughout Germany sent 1148 and 1317 carbapenem-
resistant K. pneumoniae isolates to the NRC, respectively,
and exactly 51% of them possessed a carbapenemase
[2, 3]. The most frequent carbapenemase type in these
isolates was OXA-48, followed by KPC-2/− 3 and NDM-1.
Since May 2016, Acinetobacter spp. and Enterobacteri-
aceae with carbapenem non-susceptibility are mandator-
ily notifiable to the national health authorities in
Germany. From September 2016 to August 2017, 4028
notifications were reported. The most prevalent notified
pathogen was K. pneumoniae (1147, 29%). Notifications
of carbapenem-resistant K. pneumoniae came from all
over Germany with a range of 3 to 267 notifications per
federal state. For 293 (26%) of those, a carbapenemase
was reported. The most common specified carbapene-
mases were OXA-48-like (53%), KPC-2/− 3 (17%) and
NDM-1 (12%)(A.R., A.v.L., M.A.S., unpublished data).
With this study we aimed at describing a population
snapshot of carbapenemase-producing K. pneumoniae
isolated from hospitalized patients in Germany. We
compiled a representative subset of 107 carbapenemase-
producing K. pneumoniae collected between 2008 and
2014 from all over Germany and harbouring carbapene-
mases OXA-48, KPC-2, KPC-3 and NDM-1. We per-
formed whole genome sequencing to (i) infer the
phylogenetic relatedness of corresponding isolates in-
cluding identification of the multi-locus sequence type
(MLST); (ii) extract β-lactamase- and virulence gene
content; (iii) deduce the capsule type (wzi typing); and
(iv) reconstruct the plasmid content. Finally, we com-
pared our results with K. pneumoniae isolates from clin-
ical and ambulatory settings in Europe and worldwide
(carbapenemase-producers were in the minority).
Methods
Strain collection
All carbapenemase-producing K. pneumoniae isolates in-
cluded in the study were collected during 2008 to 2014 by
the NRC and the Robert Koch Institute (RKI). We selected
a comprehensive subset of 107 strains including only
carbapenemase-producing K. pneumoniae possessing the
four most prevalent carbapenemase types in Germany
(KPC-2, KPC-3, OXA-48, NDM-1). Isolates were selected
based on a collection of 2104 strains at both participating
reference institutions (NRC n = 1904; RKI n = 200) [2]. The
selected sample set also contained type strains representing
prominent outbreaks (one isolate per setting) [4–7] and
other isolates representing previously unpublished out-
breaks which were recognized as part of the routine work
of the NRC and RKI. The isolate collection covered 12 of
the 16 federal states in Germany (Additional file 1: Figure
S1 and Additional file 2: Table S1). The number of
carbapenemase-producing K. pneumoniae isolates sent to
the NRC and RKI increased continuously until 2014; how-
ever, we tried to balance the selection of isolates over the
collection period appropriately (2010, n = 20; 2011, n = 20;
2012, n = 25; 2013, n = 22; 2014, n = 13). The distribution of
carbapenemase genes within our sample set represents the
distribution among the entire set of 2104 clinical
carbapenemase-producing K. pneumoniae isolates in both
reference institutions during the time period analysed
(blaOXA-48 n = 42, 39%; blaKPC-2 n = 34; 32%; blaKPC-3
n = 26, 24%; blaNDM-1 n = 5, 5%). Although strain
sending to the NRC or the RKI is voluntary, the annual
collection is comprehensive enough to deduce a broader
picture and allow some general assumptions [2, 8].
Whole genome sequencing (WGS)
Bacteria were grown in Brain Heart Infusion (BHI) broth.
DNA was extracted from overnight cultures using the
MagAttract Kit (Qiagen, Hilden, Germany) and the DNeasy
Blood & Tissue Kit (Qiagen) in line with the manufacturer’s
instructions. Qubit dsDNA HS Assay Kit (Invitrogen/
Thermo Fisher Scientific, Karlsruhe, Germany) was used
for DNA quantification. Sequencing libraries were prepared
applying the Nextera XT Kit (Illumina, San Diego, USA)
and sequenced on an Illumina Miseq using v3 chemistry
(2 × 300 bp) according to the manufacturer’s protocol.
Mapping-based WGS data analysis
A base quality-dependent trimming was performed for
Illumina raw reads applying Trimmomatic [9](version 0.
32, parameters: illuminaclip off, slidingwindow 4:15,
leading 3, trailing 3, crop off, headcrop off, minlen 36,
avgqual off ) using BWA-SW (version 0.7.13-r1126, de-
fault parameters) [10]. Isolates generating a high number
of ambiguous sites (cutoff: ≥15% “N” in the consensus
sequence) were excluded from the mapping and tree cal-
culation (see also Results chapter). The reference gen-
ome was selected using refRank (version 1.0.0; see
below). Single nucleotide polymorphisms (SNPs) were
called using Varscan v2.3 [11] and variant positions were
filtered using SNPfilter (version 2.2.0; see below). Based
on the aligned variant positions maximum-likelihood
trees were calculated using RAxML (version 8.2.7, model
GTR GAMMA, 100 bootstraps) [12]. Artificial Illumina
reads were generated from the FASTA-sequence down-
loaded from NCBI using ART (version 2.5.8, parameters:
system MiSeq v3, read length 250, paired end, fragment
length 600, standard deviation 300, coverage 100) [13]
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and mapped to the reference genome as described above
for the sequenced isolates.
Reference genome selection using refRank
To optimize the selection of a reference sequence for next
generation sequencing (NGS) read alignment (mapping),
we created a Python-based application called refRank,
which provides a coverage-based reference ranking. For
this purpose, datasets of paired-end or unpaired reads are
aligned against a collection of defined reference sequences
using BWA-SW [10] or BWA-MEM (arXiv:1303.3997v2
[q-bio.GN]). Computational costs can be reduced by using
only a fraction of randomly picked (paired-end) reads of
each dataset (e.g. 10% of all reads). Per base coverage is
then determined using SAMtools [14] and normalized to
the reference length and the number of total (mapped and
unmapped) reads according to a detached formula 1 de-
scribed in [15]. Dataset-specific reference ranking is based
on the calculated C scores. Additionally, a global reference
ranking based on all datasets is provided by calculating
the grand average of reference-specific C scores. The
source code for refRank is freely available under the terms
of the GNU (https://www.gnu.org/) General Public Li-
cense v3.0 from https://gitlab.com/s.fuchs/refRank.
In the present study, refRank (version 1.0.0) was used
with default parameters. The entire collection of com-
pleted genomic sequences of K. pneumoniae (n = 79) avail-
able on RefSeq (accessed on 1st Dec 2016) was used as
reference dataset. All 105 raw read datasets were trimmed
using Trimmomatic (see above) [9, 16]. According to the
reference ranking (not shown), the genomic sequence of
K. pneumoniae KPNIH30 (NZ_CP009872.1) has been se-
lected as a reference for further analysis.
Variant site filtering using SNPfilter
A python-based application called SNPfilter was devel-
oped to condense the alignment of all reconstructed se-
quences to variant positions only and, thus, to
significantly reduce computational costs of subsequent
phylogenetic analyses. Optionally, sites can be excluded
based on (i.) ambiguous base calls and/or deletions; (ii.)
SNP accumulation (based on exclusion distance); and (iii.)
user-defined regions (based on genomic coordinates). Im-
portantly, circular replicon topologies can be considered
when applying an exclusion distance for accumulated vari-
ant positions. The output of SNPfilter provides different
files containing (i.) aligned variant sites that meet the filter
criteria (FASTA format); (ii.) general information such as
sequence names, number of sites containing ambiguous
base calls or gaps, number of variants before and after fil-
tering (TXT format); and (iii.) coordinate-specific filter
status and sequence information (CSV format). The
source code for snpFilter is freely available under the
terms of the GNU General Public License v3.0 from
https://gitlab.com/s.fuchs/snpFilter [15].
In the present study sites containing gaps or ambiguous
base calls were excluded. To exclude SNPs in repetitive re-
gions and phage sequences, the reference sequence K.
pneumoniae KPNIH30 (NZ_CP009872.1) was analysed
using the repeat analysis tool in Kodon (Applied Maths)
version 3.62 and the phage search tool PHASTER [16].
Additionally, SNPs in regions of annotated phages and
transposases were rejected (not shown). Trees were illus-
trated using FigTree v1.4.3. (http://tree.bio.ed.ac.uk/soft-
ware/figtree/; last access: 25/04/2018) and iTOL v3
(https://itol.embl.de/; last access: 25/04/2018).
De novo assembly
Raw reads were trimmed applying Trimmomatic 16 (ver-
sion 0.32, parameters: Illuminaclip off, maxinfo 50:0.8,
leading 3, trailing 3, crop off, headcrop off, minlen 36,
avgqual off ). Trimmed reads were de novo assembled
using A5-miseq (version 20,150,522) [17].
WGS-based deduction of MLST, wzi type, β-lactamase and
virulence genes
WGS data of all isolates were analysed using Resfinder
[18], PlasmidFinder and the MLST tool [19] provided by
the Centre for Genomic Epidemiology (https://cge.cbs.
dtu.dk/services/; last access: 25/04/2018). Determination
of capsular type for Klebsiella strains was conducted by
wzi gene sequencing extracted from contigs derived
from de novo assembly [20] and using the websites of
the Pasteur Institute (http://bigsdb.pasteur.fr/perl/
bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef_public&-
page=downloadAlleles&scheme_id=4&render=1; last ac-
cess 25/04/2018). Furthermore, all sequenced genomes
were screened for the presence of the following virulence
genes or gene clusters using the reference databank of the
Pasteur Institute: mrk, yersiniabactin, allantionase, colibac-
tin, salmochelin, aerobactin, kfu, microcin, rmpA, rmpA2,
and kvg. Genes with mismatches or incomplete sequences
were additionally analysed in Geneious searching for
Stopp codons and inserted IS elements (Geneious v10,
Biomatters Lmtd., New Zealand). Primers used for
additional and confirmatory PCR amplification of dif-
ferent virulence and β-lactamase genes are given as a
Additional file 3: Table S2.
Phenotypic test for hypervirulence
In order to test for a putative hypervirulence or hyper-
mucoviscous phenotype, we established the so-called
‘string test’ [21]. The hypervirulent K. pneumoniae iso-
late of ST2398 possessing a K2 capsule was used as a
positive control [22].
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Results
MLST analyses
We determined the K. pneumoniae MLST types (STs)
and the carbapenemase genes from the WGS data. The
107 sequenced isolates belonged to 21 different STs.
Figure 1 shows the distribution of STs among the four
analysed carbapenemase types (OXA-48, KPC-2, KPC-3,
NDM-1). The majority of KPC-2-producing isolates
belonged to ST258 (n = 27, 80%). Three isolates were
ST147 and one each belonged to ST101, ST340, ST347
and ST784. KPC-3-producing isolates demonstrated a
low diversity; 21 isolates (81%) were ST512, four were
ST258 and one isolate was ST37. Altogether 42 OXA-
48-producing isolates revealed 15 different STs, whereas
15 isolates (36%) were ST101 and nine (21%) were
ST147. The other STs appeared less than four times.
Furthermore, one new ST (ST2254; allelic profile: gapA
_25, infB_33, mdh_141, pgi_26, phoE_7, rpoB_1, tonB_
56) with the carbapenemase gene blaOXA-48 was identi-
fied. The five NDM-1-producers that were included in
this study could be assigned to four different STs (ST15,
ST16, ST147 and ST340).
Content of additional β-lactamase genes
Besides the four corresponding carbapenemase genes, a
number of additional β-lactamase genes were deter-
mined from WGS data using ResFinder (Table 1). Five
variants of the chromosomally encoded SHV β-
lactamase were identified. SHV-11 was the most fre-
quent subtype found in 68% of isolates. However, one
OXA-48-producing and one KPC-2-producing isolate
did not show any blaSHV gene but a blaLEN gene indica-
tive of the species Klebsiella variicola. Furthermore, the
majority of isolates possessed blaTEM-1 (80%); 28% con-
tained blaOXA-1 and 11% blaOXA-9. Additional extended-
spectrum β-lactamase (ESBL) genes blaCTX-M-15 and
blaCTX-M-14 were found in 24% and 4% of the isolates,
respectively. OXA-48- and NDM-1-producing isolates
possessed an additional ESBL gene more often than
KPC-2- and KPC-3-producing isolates (Table 1).
Content of virulence genes
All but one of the 107 investigated isolates contained
three or less of the tested virulence genes or gene clus-
ters. The most frequent gene cluster was mrk encoding
regulation and expression of the type 3 pilus. Genes
mrkA, mrkB, mrkC, mrkD, mrkF, mrkH, mrkI and mrkJ
were identified in all isolates. However, the mrkH gene
was interrupted by an insertion of an IS element in 29
isolates; one of which additionally showed insertion of
an IS element in mrkI. Another isolate showed an
Fig. 1 Distribution of Klebsiella-MLST and carbapenemase types. The
columns show the relative amount of corresponding sequence type
(ST) within the group of carbapenemase-producing isolates (KPC-2,
KPC-3, OXA-48, NDM-1)
Table 1 Additional β-lactamase genes in carbapenemase-
producing K. pneumoniae isolates. Counts are given in exact
numbers and in percentages. Genes were extracted from
NGS data using ResFinder software
KPC-2 KPC-3 OXA-48 NDM-1 Total
n = 34 n = 26 n = 42 n = 5 n = 107
Chromosomal β-lactamase genes
blaSHV-1 2 (6%) – 16 (38%) 1 (20%) 19 (18%)
blaSHV-11 25 (74%) 25 (96%) 21 (50%) 2 (40%) 73 (68%)
blaSHV-12 6 (18%) – – – 6 (6%)
blaSHV-28 – – 3 (7%) 2 (40%) 5 (5%)
blaSHV-77 – – 1 (2%) – 1 (1%)
blaLEN-16 – – 1 (2%) – 1 (1%)
blaLEN-27 1 (3%) – – – 1 (1%)
Acquired β-lactamase genes
blaTEM-1 25 (74%) 23 (88%) 34 (81%) 3 (60%) 85 (80%)
blaOXA-1 – 1 (4%) 27 (64%) 2 (40%) 30 (28%)
blaOXA-9 1 (3%) – 10 (24%) 1 (20%) 12 (11%)
blaCTX-M-14 – – 4 (10%) – 4 (4%)
blaCTX-M-15 1 (3%) 1 (4%) 15 (36%) 5 (100%) 22 (21%)
blaCMY-2 – – 1 (2%) – 1 (1%)
blaVEB-1 1 (3%) – – – 1 (1%)
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insertion within the mrkJ gene. Correspondingly, only 77
isolates (72%) possessed an entire mrk gene cluster
(Additional file 1: Figure S2). Strikingly, in 26 of 29
strains the insertion site in mrkH was completely identi-
cal. The ORF was destroyed after 207 nucleotides by the
introduction of an IS element (93% identity to ISEc21
according to ISfinder [23]). These 26 isolates were KPC-
2 producers of ST258 (wzi_29). Yersiniabactin was the
second most frequent virulence factor. Two isolates pos-
sessed a premature STOP codon in each gene (ybtA and
irp2). Accordingly, 36% of all isolates harboured a
complete and putatively functional yersiniabactin cluster.
The kfu gene cluster was identified in 21% (n = 22) in-
cluding all isolates of ST101 (n = 16) and ST15 (n = 4).
Genes encoding the siderophore aerobactin were de-
tected in six isolates.
The single ST23 isolate producing OXA-48 (no. 316/
15) was exceptional by harbouring a great repertoire of
virulence genes showing hits for all tested targets ex-
cept kvg (Additional file 3: Table S3). The ORF of
rmpA2 demonstrated a premature stop codon (see also
Discussion). Due to the high number of virulence genes
the so-called ‘string test’ was performed to identify a
putative hypermucoviscous phenotype associated with
hypervirulence; however, the test result was repeatedly
negative.
Identifying the capsule type (wzi typing)
NGS data were used to extract wzi allele variants which
finally deduced the corresponding capsule type [20]. De-
tails are given in Additional file 3: Table S4. Altogether
25 wzi alleles were identified including five new variants
that received new allele types after submission to the
corresponding database at the Pasteur Institute, Paris.
One isolate did not reveal any wzi result, either from
analysing NGS data or from performing wzi-specific
PCRs (Additional file 3: Tables S2/S4; isolate 274/15,
ST147). Isolates of a single ST did not always possess
the same wzi allele. For instance, K. pneumoniae ST15
isolates possessed three wzi alleles (wzi_24, wzi_19 and
wzi_new1). Isolates of ST147 also possessed three differ-
ent allele types; however, the vast majority were associ-
ated with wzi_64. Eighty-four percent (26/31) of ST258
isolates contained the wzi_29 allele, which is equivalent
to capsule cluster type cps1. All these isolates also pro-
duced KPC-2. In contrast, all KPC-3-producing ST258
isolates showed wzi_154 (associated with the cps2 clus-
ter). All isolates of ST512 (n = 21) contained wzi_154.
The single ST23 isolate no. 316/15 possessing a high
number of virulence genes possessed wzi_1 which is as-
sociated with capsule type K1. It has been described that
K. pneumoniae with capsule type K1 belong to the group
of hypervirulent strain types [24].
Plasmid content
Using the tool PlasmidFinder the plasmid content and
the equivalent incompatibility (Inc) groups were ex-
tracted from NGS data (Fig. 2). Most frequent were
IncFII(K) and IncFIB(K) occurring in 76% and 68% of all
isolates, respectively. All KPC-2- and KPC-3-producing
isolates possessed IncFII(K) and approximately 90% also
possessed IncFIB(K). Seventy-three percent of KPC-2-
and KPC-3-producing isolates were positive for IncX3.
All NDM-1-producing isolates showed a positive result
for IncFIB whereas all OXA-48-producing K. pneumo-
niae isolates possessed IncL/M (IncL/M(pMU407) or
IncL/M(pOXA-48)). Furthermore, the majority of OXA-
48-producing isolates contained an IncR plasmid (62%).
Phylogeny of carbapenemase-producing K. pneumoniae
isolates from Germany
Searching for β-lactamase genes in NGS data revealed
two isolates with a blaLEN gene indicative of the species
K. variicola (isolates no. 275/15 and no. 328/15). In
silico restriction of gyrA with TaqI und HaeIII confirmed
their association with phylogroup III and species K. var-
iicola, respectively. Accordingly, these two isolates were
not considered for subsequent phylogenetic analysis.
Phylogenetic comparison was done using a reference-
based mapping approach. The best reference was selected
by refRank, suggesting K. pneumoniae isolate KPNIH30
(NCBI-no. NZ_CP009872.1) as best match. One of the K.
variicola isolates (ST906, OXA-48) was included to
root the tree. Two K. pneumoniae isolates (no. 301/15
[blaOXA-48; ST16] and no. 330/15 [blaOXA-48; ST48])
were excluded from the mapping and tree calculation due
to a high number of ambiguous sites (cutoff: ≥15% “N” in
the consensus sequence). After excluding repetitive re-
gions and mobile genetic elements, 159,154 SNP positions
(length of the reference genome: 5,306,618 bp) remained
to construct the maximum likelihood tree (Fig. 3).
Among the 103 analysed carbapenemase-producing K.
pneumoniae isolates four major clusters could be identi-
fied corresponding to sequence types ST258, ST512,
ST147, and ST101. A strong association between the
MLST type and carbapenemase type was noticeable for
isolates of ST258, ST512, and ST101. The ST512 isolates
contained KPC-3 exclusively. Furthermore, the vast ma-
jority of ST258 isolates possessed KPC-2. All but one
isolates of ST101 produced OXA-48. In contrast, ST147
isolates produced mainly OXA-48, and to a lesser extent
also KPC-2 and NDM-1. Isolates of ST11 and ST340
constitute a clonal group CG258 together with isolates of
ST258 and ST512, a detailed view is given in Additional
file 1: Figure S3. ST512 isolates formed a sub-cluster
within CG/ST258 isolates. Within the CG/ST258 cluster
three subgroups were noticeable which correlate with the
results of the wzi typing. All isolates of ST258 associated
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with the wzi_29 built a separate cluster as well as the four
ST258 isolates with the wzi_154 allele. The latter were lo-
cated on a separate branch and clearly different from
ST512 possessing the wzi_154 allele as well. One single
isolate of ST258 possessed wzi_83, but was clearly sepa-
rated from all other CG258 isolates. The association of the
wzi allele and the carbapenemase type was even stricter
than with the sequence type; wzi_154 was always linked to
KPC-3 and wzi_29 was exclusively associated with KPC-2.
Phylogeny of carbapenemase-producing K. pneumoniae
isolates from Germany in the international context
To reconstruct a phylogeny of the German carbapenemase-
producing K. pneumoniae isolates in relation to clinical
K. pneumoniae from other countries, we performed
NGS-based analysis with K. pneumoniae genomes from
our study and two other collections (irrespective of the
carbapenemase type or resistance phenotype in general):
all human K. pneumoniae isolates (KpnI) described in
the study by Holt et al., 2015 [25] and all completely
closed K. pneumoniae genomes in the ncbi Genome
Database (https://www.ncbi.nlm.nih.gov/genome/; 12/
2016). In preparation of the analysis, completely
closed genomes were artificially separated into MiSeq
reads and subsequently all NGS data from MiSeq and
HiSeq [25] runs were subjected to a reference-based
mapping as described before but using K. pneumoniae
subsp. pneumoniae NTUH-K2044 (NCBI-no. NC_012731.
1; was also used as a reference by Holt et al., [25]). Isolates
with more than 15% ambiguities were excluded from sub-
sequent analyses resulting in a tree consisting of 337 K.
pneumoniae isolates including 99 isolates from our study
and 238 isolates from the other two studies (Holt collec-
tion: 167; ncbi: 71). After excluding repetitive regions and
mobile genetic elements 126,347 SNPs remained to recon-
struct an ML tree (Fig. 4). The majority of the other
Fig. 2 Identified plasmid replicons in 107 carbapenemase-producing K. pneumoniae isolates using NGS data and PlasmidFinder software. The inc
groups were presented at the y axis and the color code refers to the corresponding carbapenemase genes (see legend)
Becker et al. Antimicrobial Resistance and Infection Control  (2018) 7:62 Page 6 of 12
isolates originated from Asia (n = 139), followed by Amer-
ica (n = 59) and Australia (n = 33). Furthermore, the col-
lection included seven European isolates, three from
Greece; one each from Switzerland and France and two
from Germany (independent from the present collection).
NGS analyses revealed 116 MLST types within the whole
collection, 36 of which appeared more than once (the
MLST type of 16 isolated could not be determined). The
238 international isolates comprised 108 different MLST
types, 33 of which appeared more than once, demonstrat-
ing a much higher diversity than identified for the 99 iso-
lates from this study from Germany only (21 MLST
types). The largest clusters were formed by isolates be-
longing to ST11, ST14, ST15, ST23, ST101, ST147, ST258
and ST512. The ST14 cluster only contained isolates from
international collections whereas the ST101 cluster exclu-
sively showed isolates from Germany. Clusters ST15,
ST147, ST258, and ST512 demonstrated an intermingled
subset structure consisting of German and international
K. pneumoniae isolates. ST23 was the most frequent
MLST type in Asia but was found only once in Germany.
We also took a closer look into the CG/ST258 cluster
isolates (66 of the 337 isolates; Additional file 1: Figure
S4). The majority of isolates derived from the German
collection (n = 48), another 18 were deposited in Gen-
Bank as complete genomes and originated from
America/USA (n = 17) and Switzerland (n = 1). All
international ST258 and ST512 isolates also possessed
a carbapenemase gene. All American isolates were of
ST258 and the Swiss isolate was ST512. All but two iso-
lates contained the wzi_154 or wzi_29 alleles (wzi_150 in
isolate NZ_CP010392.1; wzi_83 in no. 278/15). The two
isolates demonstrating unique wzi alleles were also dis-
tantly related to the rest. A strong association between
carbapenemase type and wzi allele type was identified, as
already shown for the German isolates; KPC-2 was always
linked to wzi_29 and KPC-3 to wzi_154. Within the
ST258 group, isolates possessing KPC-2 (wzi_29) from
Fig. 3 Phylogeny of 103 carbapenemase-producing K. pneumoniae isolates from German hospital patients, 2008-2014. The image shows a ML tree
based on 159.154 SNPs of the core genome. A K. variicola isolate (ST906, OXA-48) served as an outgroup to root the tree (the corresponding
branch is shortened 1/100). Clades of three or more isolates received an alternating colour code grey/blue. The clades are labelled with the
corresponding MLST type. The outer ring corresponds to the four different carbapenemase (see Figure legend for colour code). The colour of the
branches correlate with the corresponding boostrap value (light red (0) to black (100))
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Germany and America formed two separate sub-clusters.
The same situation was noticeable for ST258 possessing
KPC-3 (wzi_154). Neither finding indicates a recent
exchange of isolates between Germany and the US. In
contrast, the Swiss isolate (NZ_CP015822.1) clustered to-
gether with all the German ST512 isolates.
Discussion
More than half of the study sample (58/105; 2× K. varii-
cola) belonged to the prominent and worldwide distrib-
uted clonal group CG258, including ST258, ST512,
ST11, ST395, and ST340. In collections from other
countries and continents ST258 and ST11 were the most
frequent sequence types within CG258 [26]. Isolates of
ST258 are worldwide frequently associated with KPC-2,
a finding which was also confirmed for the situation in
Germany. SNP-based analyses of ST258/KPC-2 and
ST512/KPC-3 showed a clear genetic separation of isolates
from Europe and the United States (Additional file 1: Figure
S4). This indicates a circulation of KPC clones in Europe.
The first outbreak due to K. pneumoniae-ST258 with KPC-
2 was reported in 2008 in Germany, and the index patient
had been previously hospitalized in Greece [27]. Routine
screening for carbapenemase-producing K. pneumoniae is
mandatory at hospital admission in Germany only as part
of a risk-based adapted approach (considering certain risk
factors such as having received hospital treatment in a
high-risk country) and thus patients with undetected
colonization may contribute to their further spread within
Germany [8].
In contrast to ST258, carbapenemase-producing ST11
(CG258) isolates are quite frequent in Asia. In our collec-
tion we found only one ST11 isolate indicating that this ST
has so far occurred only rarely in Germany. ST395 isolates,
representing another CG258 type, appeared three times in
our collection and were always associated with OXA-48.
Fig. 4 Phylogeny of carbapenemase-producing isolates from Germany, 2008-2014 in relation to an international K. pneumoniae isolate collection.
The image shows a ML tree based on 126.347 SNPs for 99 carbapenemase-producing isolates from Germany and 238 international K. pneumoniae
isolates. The tree was rooted midpoint. Clades represented by two or more isolates were colour-coded/shaded (grey/blue) and the MLST type is
listed. The outer ring corresponds to the origin of the strains given as a colour code (see Figure legend). The colours of the branches correlate
with the corresponding boostrap value (light red (0) to black (100))
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OXA-48-producing K. pneumoniae isolates of ST395 were
also found recently in other European countries, such as
France, the Netherlands and Hungary [28–32].
The present collection also contained a cluster of
ST101 isolates (n = 16), 15 of which were OXA-48 pro-
ducers. Although the two external collections included
in the phylogenetic analysis did not contain ST101 K.
pneumoniae, the combination ST101-OXA-48 is not
unique to Germany. Clinical isolates with these charac-
teristics were described in neighbouring European coun-
tries in recent years, such as Czech Republic, France and
Belgium [28, 33, 34], and also all over Europe and North
Africa [29, 35]. ST101 isolates seem to be especially dis-
tributed in Europe, and also mainly associated with
OXA-48 [36]. Two further clusters were formed by
ST147 and ST15 isolates producing mainly OXA-48 but
also NDM-1 and/or KPC-2 (Fig. 3). Both clonal lineages
of K. pneumoniae are well known as colonizers or the
cause of infection in human patients; outbreaks due to
ST147 with OXA-48 have been reported in Germany
and ST15 with OXA-48 was also found in pets in a Ger-
man veterinary clinic [37, 38].
Due to the presence of the blaLEN gene and the gyrA se-
quence two of the 107 isolates were classified as K. varii-
cola (phylogroup Kpn III). The same MLST scheme is
used for all three phylogroups and all species K. variicola,
K. pneumoniae and Klebsiella quasipneumoniae, respect-
ively [36]. The OXA-48 producing K. variicola isolate of
ST906 represents a very rare ST and ST/carbapenemase
combination. ST906 was first defined in a set of strains
from an Israeli clinic [39]. However, the authors failed to
proof the species K. variicola. K. variicola isolates of
ST347 were described in previous studies from China,
Japan, Greece and Sweden [40–43]. However, only the
Greek isolate was a carbapenemase producer (KPC-2)
[42]. In general, reports about carbapenemase-producing
K. variicola are rare; we found a report about OXA-181-
producing K. variicola from vegetables imported from
Asia to Europe [44] and NDM-producing isolates originat-
ing from a river in China [45]. In a very recent study per-
formed in the US an ST906-isolate producing NDM-1
was also identified as K. variicola [46].
One isolate was clearly separated from the rest of our col-
lection regarding the presence of virulence genes: the
OXA-48-producing ST23 isolate no. 316/15, carrying cap-
sule type K1 and containing all but one tested virulence
markers including different siderophore genes (Additional
file 3: Table S3). ST23 isolates are known to be hyperviru-
lent and can cause severe infections in apparently healthy
individuals [47, 48]. In particular, ST23 isolates expressing
the K1 capsule were frequently associated with cases of
community-acquired pyogenic liver abscesses and occurred
predominantly in Asian countries [24, 48]. Our single ST23
isolate originated from a tracheal secretion suggesting a
respiratory tract infection. Subsequent molecular analyses
by XbaI macrorestriction and pulsed field gel electrophor-
esis of isolates from the same diagnostic laboratory revealed
that this isolate belonged to a cluster of seven isolates that
occurred in the period February 2012 to July 2012. The
sample isolates originated from three blood cultures, one
urine sample and several swabs. No further clinical or pa-
tient information was available for these isolates. Hypervir-
ulent strains of K. pneumoniae often express a typical
hypermucoviscous phenotype and demonstrate a small
spectrum of resistances, mainly only to penicillins, e.g.
ampicillin. Our ST23 isolate contained various β-lactamase
genes, including classical β-lactamases (blaSHV-11, blaTEM-1,
blaOXA-1), ESBLs (blaCTX-M-15) and carbapenemases
(blaOXA-48). A quick, so-called ‘string test’ for identifying a
hypermucoviscous phenotype was negative, possibly associ-
ated with the premature STOP codon in the rmpA2 gene
(regulator of the mucoid phenotype A gene). However, the
string test gives only a hint and is not reliable enough to
predict a corresponding clinical behaviour. In addition, we
do not know whether this mutation was also prevalent in
the other clonally related isolates that were not available for
a genome-based analysis. The combination of hyperviru-
lence and resistance to last-line therapeutics is highly worri-
some and has just recently raised serious public health
concerns [49–51].
A number of recent reports have suggested that the wzi
locus is frequently exchanged between K. pneumoniae iso-
lates [52, 53] and, as such, could be putatively genetically
linked to other, horizontally exchanged markers, such as
plasmid-located carbapenemase genes. In particular, the
highly successful ST258 clone seemed to be a hybrid
strain with the cps locus (containing the wzi gene) located
next to a recombination hotspot [54]. Although KPC-2/3,
OXA-48 and NDM-1 genes are commonly located on
plasmids, a chromosomal integration is also reasonable, at
least for some carbapenemase genes. It has been described
recently, that blaKPC-2 could also be chromosomally deter-
mined via IS-mediated Tn4401 transposition into specific
chromosomal loci, especially observed in CG258 isolates
(ST11, ST258, ST340) [55]. Although we could not prop-
erly elucidate plasmid structures by assembling Miseq
reads, we suggest a plasmid localization of the carbapene-
mase genes in most cases based on the sum of assembled
and interpreted NGS data. The finding of IncFII se-
quences in KPC-producing CG258 isolates and IncL/M
sequences in all OXA-48 producers supports our sugges-
tion because these associations of carbapenease genes and
plasmid replicon types are well known [53, 56].
ST258 isolates (our collection and genomes of inter-
national isolates included in the study) contained four wzi
alleles; wzi_29 (n = 26); wzi_154 (n = 4); wzi_83 (n = 1) and
wzi_150 (n = 1). Similar distributions were described in
two recent studies performed in the US [52, 57] The
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association within ST258 isolates of cps1/wzi_29 with
blaKPC-2 and cps2/wzi_154 with blaKPC-3, respectively, was
identified for our study sample of German clinical isolates
but was also described for isolates from other studies and
countries [54, 58, 59]. Bowers et al., supposed that the as-
sociation of cps1 in KPC-2-producing K. pneumoniae iso-
lates and of cps2 in KPC-3-positive isolates is derived
from the fact that the point mutations in blaKPC leading to
a differentiation into blaKPC-2 and blaKPC-3 appeared at
the same time when the two clades with different cps loci
diverged [58]. All of the ST512 isolates in our study con-
tained blaKPC-3 and wzi-154; which is identical to all
blaKPC-3-positive K. pneumoniae isolates of ST258 in a re-
cent study performed in Italy. Thus, our results presented
for German isolates confirm previous findings performed
on blaKPC-positive CG258 isolates (ST258, ST512) from
Italy [59]. In all ST512 isolates from Italy only wzi_154
was present. This exclusive association among a compre-
hensive set of 461 K. pneumoniae isolates collected all
over the country led the authors of the previous study to
assume that ST512 isolates may have originated from
ST258-cps2-clade strains [59].
Limitations
Our study has some limitations. First, strain sending to ref-
erence laboratories is voluntary and taking this into consid-
eration we cannot exclude any bias in our strain collection,
which served as the basis to select representative isolates for
further genome-based analysis. Second, clinical and patient
data available with the strains submitted were limited. We
could not perform any analysis in this regard, nor could we
provide additional clinical and patient information to the
data that are already provided. Third, we are well aware that
even a collection of about 100 strains representing 12 fed-
eral states in Germany and a timeframe of 7 years does not
allow statistically significant assumptions (which we have
not calculated and specified as such). Fourth, it has already
been addressed in previous papers that plasmid content is
difficult to reconstruct with Miseq data, thus the location of
the carbapenemase gene on a specific plasmid could and, in
consequence, a potential spread of distinct carbapenemase
gene-carrying plasmids not be identified. Correspondingly,
the putative link between plasmid types and carbapenemase
genes remains to a certain extent hypothetical. Fifth, in the
last 2 years, data from the NRC showed a rapid increase of
Enterobacteriaceae (including K. pneumoniae) isolates pro-
ducing VIM-1 in Germany [2], but this trend could not be
considered when this study was initiated.
Conclusion
Using WGS-based analysis we were able to describe a
population snapshot of clinical, carbapenemase-producing
K. pneumoniae isolates from hospitalized patients in
Germany collected between 2008 and 2014. This revealed a
preferred prevalence of KPC-2-producing ST258 isolates
and KPC-3-producing ST512 isolates. OXA-48 is the most
prevalent carbapenemase type in Germany and was shown
to be associated with various K. pneumoniae strain types,
most of them possessing IncL/M plasmid replicons,
suggesting a preferred dissemination of blaOXA-48 via this
well-known plasmid type. We identified a supposed hyper-
virulent ST23 strain of capsule type K1-producing OXA-
48, which turned out to be representative for an entire clus-
ter of infections in a single German health-care centre in
2012. This finding demonstrated that this highly pathogenic
and multidrug-resistant K. pneumoniae strain type, associ-
ated with a serious public health threat outside Asia and
within Europe, had already appeared several years ago.
Additional files
Additional file 1: Figure S1. Origin of the 107 German carbapenemase-
producing K. pneumoniae isolates. Regions are shown, where isolates origi-
nated from. Isolates from Saxony could not be elucidated further due to the
lack of additional geographic information. Number of isolates is given by
the size of the circle (see legend). Image is from: © Bundesamt für Kartogra-
phie und Geodäsie, Frankfurt am Main, Germany. Figure S2. Virulence gene
content in 107 carbapenemase-producing K. pneumonaie isolates from
Germany. Data are given in % of isolates showing possession of the corre-
sponding gene cluster. The graph shows four most frequent virulence
genes identified in more than one single isolate. Figure S3. Detailed view
of the ML tree concerning ST258/ST512 – carbapenemase-producing K.
pneumoniae isolates from Germany, 2008-2014. The image shows a subtree
of Fig. 3 containing 52 isolates of ST258 (light violett) and ST512 (grey).
Colour codes of the inner ring designate the corresponding carbapenemase
type, the outer designates the wzi allele (see legend). Figure S4. ML tree of
NGS-based analysis of German K. pneumoniae isolates and isolates from an
international collection - detailed view of the cluster ST258/ST512 isolates.
The image shows a subtree of Fig. 4 containing 66 isolates of ST258 and
ST512. Colour codes of the inner ring correspond to the origin of strains,
the middle ring to the carbapenemase KPC-2 or KPC-3, and the outer ring
demonstrates the wzi allele type. (PPTX 1367 kb)
Additional file 2: Table S1. Metadata of the 107 German
carbapenemase-producing, clinical Klebsiella isolates, 2008-2014. Isolates
were ordered by carbapenemase type. For more information see main
text document. (XLSX 54 kb)
Additional file 3: Table S2. Names and sequences of used primers for
MLST and PCR amplification of virulence genes and β-lactamase genes.
Table S3. Identified virulence genes in K. pneumoniae isolate no. 316/15
(ST23, OXA-48). Table S4. Identified wzi alleles from NGS data of 107
carbapenemase-producing K. pneumoniae from Germany. (DOCX 35 kb)
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